S. Desai

发表

Factors associated with diarrhoea in young children and incidence of symptomatic rotavirus infection in rural West Bengal, India

S. Panda, M. Chawla-Sarkar, S. Ganguly, 2014, Epidemiology and Infection.

A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

G. Kang, Dinesh Kumar, S. Juvekar, 2017, Vaccine.

Bovine rotavirus pentavalent vaccine development in India.

P. Kulkarni, R. Dhere, S. Desai, 2014, Vaccine.

Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial.

S. Madhi, A. Gutschmidt, M. Tameris, 2022, The Lancet. Infectious diseases.

A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

G. Kang, N. Gogtay, A. Dubey, 2018, Vaccine.

Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infants.

G. Kang, S. Juvekar, A. Bavdekar, 2019, Vaccine.

Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine☆

N. Gogtay, A. Dubey, Yuxiao Tang, 2018, Vaccine.

Safety and tolerability of a liquid bovine rotavirus pentavalent vaccine (LBRV-PV) in adults.

P. Kulkarni, C. Bhamare, S. Desai, 2018, Vaccine.